Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives
Abstract Hepatocellular carcinoma (HCC) is a highly malignant tumor with elevated incidence and mortality rates globally. Its complex etiology and pronounced heterogeneity present significant challenges in diagnosis and treatment. Recent advancements in artificial intelligence (AI) have demonstrated...
Saved in:
| Main Authors: | Wei Ding, Jinxing Zhang, Zhicheng Jin, Hongjin Hua, Qingquan Zu, Shudong Yang, Weidong Wang, Sheng Liu, Haifeng Zhou, Haibin Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03254-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling key pathomic features for automated diagnosis and Gleason grade estimation in prostate cancer
by: Valentina Brancato, et al.
Published: (2025-07-01) -
Integrating pathomics and deep learning for subtyping uveal melanoma: identifying high-risk immune infiltration profiles
by: Qi Wan, et al.
Published: (2025-07-01) -
Comprehensive analysis of GPN1 in human cancer and its effects on the migration of hepatocellular carcinoma cells
by: Rongtao Zhu, et al.
Published: (2024-11-01) -
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma
by: Pietro Guerra, et al.
Published: (2025-07-01) -
Leveraging diverse cell-death patterns to predict to predict prognosis and immunotherapy in hepatocellular carcinoma
by: Xiaoxiang Zhang, et al.
Published: (2025-08-01)